LEICA BIOSYSTEMS NEWCASTLE LTD
Main Filters
LEICA BIOSYSTEMS NEWCASTLE LTD
| LEICA BIOSYSTEMS NEWCASTLE LTD | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| CS9100 | 0 | - | ||
| DS9263 | 0 | - | ||
| DS9713 | 0 | - | ||
| DS9800 | 0 | - | ||
| NCL-d-SARC | 0 | - | ||
| NCL-DRP2 | 0 | - | ||
| NCL-DYS1 | 0 | - | ||
| NCL-DYS2 | 0 | - | ||
| NCL-DYS3 | 0 | - | ||
| NCL-EMERIN | 0 | - | ||
| NCL-g-SARC | 0 | - | ||
| NCL-HAMLET | 0 | - | ||
| NCL-Hamlet-2 | 0 | - | ||
| NCL-L-CD11c-563 | 0 | - | ||
| NCL-L-CD19-163 | 0 | - | ||
| NCL-L-CD1a-235 | 0 | - | ||
| NCL-L-CD2-271 | 0 | - | ||
| NCL-L-CD20-L26 | 0 | - | ||
| NCL-L-CD21-2G9 | 0 | - | ||
| NCL-L-CD23-1B12 | 0 | - | ||
| NCL-L-CD3-565 | 0 | - | ||
| NCL-L-CD30-591 | 0 | - | ||
| NCL-L-CD33 | 0 | - | ||
| NCL-L-CD38-290 | 0 | - | ||
| NCL-L-CD5-4C7 | 0 | - | ||
| NCL-L-CD7-580 | 0 | - | ||
| NCL-L-CD79a-225 | 0 | - | ||
| NCL-L-CEA-2 | 0 | - | ||
| NCL-L-CK20 | 0 | - | ||
| NCL-L-CK20-561 | 0 | - | ||
| NCL-L-CK5 | 0 | - | ||
| NCL-L-CK7-560 | 0 | - | ||
| NCL-L-CK7-OVTL | 0 | - | ||
| NCL-L-CK8-TS1 | 0 | - | ||
| NCL-L-CYCLIND1-GM | 0 | - | ||
| NCL-L-DES-DERII | 0 | - | ||
| NCL-L-DOG-1 | 0 | - | ||
| NCL-L-EGFR | 0 | - | ||
| NCL-L-EMA | 0 | - | ||
| NCL-L-END | 0 | - | ||
| NCL-L-ER-6F11 | 0 | - | ||
| NCL-L-EXH2 | 0 | - | ||
| NCL-L-FRALPHA | 0 | - | ||
| NCL-L-GCDFP15 | 0 | - | ||
| NCL-L-Geminin | 0 | - | ||
| NCL-L-GRAN-B | 0 | - | ||
| NCL-L-IgA | 0 | - | ||
| NCL-L-IgD | 0 | - | ||
| NCL-L-IgM | 0 | - | ||
| RTU-CD15 | 0 | - | ||
708 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD11c-563 is intended for the qualitative identification by light microscopy of human CD11c antigen in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
RTU-CD15 is intended for the qualitative identification by light microscopy of CD15 molecules in paraffin sections
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD19-163 is intended for the qualitative identification by light microscopy of human CD19 in paraffin sections. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD1a-235 is intended for the qualitative identification by light microscopy of human CD1a molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD2-271 is intended for the qualitative identification by light microscopy of CD2 (LFA-2) molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD20-L26 is intended for the qualitative identification by light microscopy of CD20 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD21-2G9 is intended for the qualitative identification by light microscopy of CD21 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD23-1B12 is intended for the qualitative identification by light microscopy of human CD23 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD3-565 is intended for the qualitative identification by light microscopy of human CD3 antigen in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD30-591 is intended for the qualitative identification by light microscopy of CD30 protein in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD33 is intended for the qualitative identification by light microscopy of human CD33 in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD38-290 is intended for the qualitative identification by light microscopy of CD38 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD5-4C7 is intended for the qualitative identification by light microscopy of human CD5 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD7-580 is intended for the qualitative identification by light microscopy of human CD7 antigen in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CD79a-225 is intended for the qualitative identification by light microscopy of CD79a molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CEA-2 is intended for the qualitative identification by light microscopy of human carcinoembryonic antigen in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CK20-561 is intended for the qualitative identification by light microscopy of Cytokeratin 20 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CK20 is intended for the qualitative identification by light microscopy of human cytokeratin 20 intermediate filament protein in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CK5 is intended for the qualitative identification by light microscopy of Cytokeratin 5 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CK7-560 is intended for the qualitative identification by light microscopy of Cytokeratin 7 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CK7-OVTL is intended for the qualitative identification by light microscopy of Cytokeratin 7 molecules in paraffin sections
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Analyte Specific Reagent. Analytical and performance characteristics are not established.
0
-
BOND™
LEICA BIOSYSTEMS NEWCASTLE LTD
The BOND Aspirating Probe Cleaning System is intended for automated cleaning of aspirating probes on BOND instruments, using the aspirating probe cleaning protocol installed in BOND systems (includes Leica BOND-MAX system and Leica BOND-III system).
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-CYCLIN D1-GM is intended for the qualitative identification by light microscopy of Cyclin D1 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-d-SARC is intended for the qualitative identification by light microscopy of Delta-Sarcoglycan by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-DES-DERII is intended for the qualitative identification by light microscopy of human desmin in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-DOG-1 is intended for the qualitative identification by light microscopy of human DOG-1 in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-DRP2 is intended for the qualitative identification by light microscopy of Utrophin (N-terminus) by immunohistochemistry.
0
-
BOND
LEICA BIOSYSTEMS NEWCASTLE LTD
BOND Intense R Detection is a biotin/streptavidin system for the detection of tissue-bound primary antibodies. It is intended for staining sections of formalin-fixed, paraffin-embedded tissue on the BOND automated system (includes Leica BOND-MAX system and Leica BOND-III system).
0
-
BOND
LEICA BIOSYSTEMS NEWCASTLE LTD
BOND Polymer Define Detection is a biotin-free, polymeric horseradish peroxidase (HRP)-linker antibody conjugate system for the detection of tissue-bound mouse and rabbit IgG and some mouse IgM primary antibodies.
0
-
BOND
LEICA BIOSYSTEMS NEWCASTLE LTD
BOND Polymer Refine Detection is a biotin-free, polymeric horseradish peroxidase (HRP)-linker antibody conjugate system intended for the visualization of tissue-bound mouse IgG, mouse IgM and rabbit primary antibodies.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-DYS1 is intended for the qualitative identification by light microscopy of Dystrophin (Rod Domain) by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-DYS2 is intended for the qualitative identification by light microscopy of Dystrophin (C-terminus) by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-DYS3 is intended for the qualitative identification by light microscopy of Dystrophin (N-terminus) by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-EGFR is intended for the qualitative identification by light microscopy of Epidermal Growth Factor Receptor molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-EMA is intended for the qualitative identification by light microscopy of Epithelial Membrane Antigen molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-EMERIN is intended for the qualitative identification by light microscopy of Emerin by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-END is intended for the qualitative identification by light microscopy of human CD34 molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
Estrogen Receptor Clone 6F11 (ER 6F11) Mouse Monoclonal antibody is intended for laboratory use to qualitatively identify estrogen receptor (ER)antigen in sections of formalin fixed, paraffin embedded breast cancer tissue by immunohistochemistry methods.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-EZH2 is intended for the qualitative identification by light microscopy of EZH2 (Enhancer of Zeste Homolog 2 (Drosophila)) molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-FRalpha is intended for the qualitative identification by light microscopy of folate receptor alpha (FR alpha) molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-g-SARC is intended for the qualitative identification by light microscopy of Gamma-Sarcoglycan by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-GCDFP15 is intended for the qualitative identification by light microscopy of gross cystic disease fluid protein (15 kD) molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-Geminin is intended for the qualitative identification by light microscopy of Geminin molecules in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-GRAN-B is intended for the qualitative identification by light microscopy of Granzyme B molecules in paraffin sections. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-Hamlet-2 is intended for the qualitative identification by light microscopy of Dysferlin by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-Hamlet is intended for the qualitative identification by light microscopy of Dysferlin by immunohistochemistry.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-IgA is intended for the qualitative identification by light microscopy of human immunoglobulin A (IgA) molecules in paraffin sections
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-IgD is intended for the qualitative identification by light microscopy of Immunoglobulin D in paraffin sections.
0
-
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD
NCL-L-IgM is intended for the qualitative identification by light microscopy of immunoglobulin M in paraffin sections.
